Skip to content

Public FDA record

Z-2490-2019: This is an in vitro diagnostic product intended for use as a calibration serum in clinical chemistry assa

Recall record Z-2490-2019 for Randox Laboratories Ltd.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2490-2019
Company in FDA record
Randox Laboratories Ltd.
FDA record creation date
Sep 7, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

Randox Laboratories realigned RX Analyser Series calibration targets by 10% for AST and 9% for ALT in line with the Mean of All Instrument method target for the Randox Calibration Serum Level 3 (for calibrator lot 961UE onwards).

Source facts

Action
Randox Laboratories Ltd. issued Urgent Medical Device Correction letter on 7/12/19 advising users of the problem, health risk and action to take: Replace all Quality Control value sheets with the revised sheets available on www.randox.com . Discuss the contents of this notice with your Medical Director. Complete and return the response form 12187-QA to technical.services@randox.com within five working days.
Initiated
2019-07-12
Root cause
Under Investigation by firm
Terminated
2020-06-17
Distribution
Nationwide Foreign: Antigua, Aruba, Bahamas, Granada, Tobago,
Recall number
Z-2490-2019
Recall status
Terminated
CDRH record ID
174986
FDA record created
2019-09-07
Recall event number
83373

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗